4.6 Review

Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM)

期刊

EXPERT OPINION ON DRUG DELIVERY
卷 18, 期 7, 页码 849-876

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/17425247.2021.1873273

关键词

Central nervous system (CNS); cerebrovascular diseases; cerebral cavernous malformation (CCM); inflammation; oxidative stress; nanosystems; nanodiagnostics; nanotherapeutics; nanotheranostics; nose-to-brain delivery

资金

  1. Telethon Foundation [GGP15219]
  2. Fondazione CRT (Cassa di Risparmio di Torino)
  3. Universita degli Studi di Torino

向作者/读者索取更多资源

Cerebrovascular diseases encompass a variety of brain vasculature disorders and are major causes of mortality and disability worldwide. They can be inherited, with common pathogenetic roles of oxidative stress and inflammation. Nanomedicine strategies may offer innovative features for early detection and treatment of such diseases.
Introduction: Cerebrovascular diseases encompass various disorders of the brain vasculature, such as ischemic/hemorrhagic strokes, aneurysms, and vascular malformations, also affecting the central nervous system leading to a large variety of transient or permanent neurological disorders. They represent major causes of mortality and long-term disability worldwide, and some of them can be inherited, including Cerebral Cavernous Malformation (CCM), an autosomal dominant cerebrovascular disease linked to mutations in CCM1/KRIT1, CCM2, or CCM3/PDCD10 genes. Areas covered: Besides marked clinical and etiological heterogeneity, some commonalities are emerging among distinct cerebrovascular diseases, including key pathogenetic roles of oxidative stress and inflammation, which are increasingly recognized as major disease hallmarks and therapeutic targets. This review provides a comprehensive overview of the different clinical features and common pathogenetic determinants of cerebrovascular diseases, highlighting major challenges, including the pressing need for new diagnostic and therapeutic strategies, and focusing on emerging innovative features and promising benefits of nanomedicine strategies for early detection and targeted treatment of such diseases. Expert opinion: Specifically, we describe and discuss the multiple physico-chemical features and unique biological advantages of nanosystems, including nanodiagnostics, nanotherapeutics, and nanotheranostics, that may help improving diagnosis and treatment of cerebrovascular diseases and neurological comorbidities, with an emphasis on CCM disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据